Where does Scion Neurostim, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Scion Neurostim, Inc. ranks #10,168 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Scion Neurostim, Inc. hold?

Scion Neurostim, Inc. holds 31 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Scion Neurostim, Inc.'s Innovation Score?

Scion Neurostim, Inc. has an Innovation Score of 42.3 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Scion Neurostim, Inc.'s patent grant rate increasing or decreasing?

Scion Neurostim, Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Scion Neurostim, Inc.'s patents?

Scion Neurostim, Inc.'s patents average 30.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Scion Neurostim, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Scion Neurostim, Inc.

Q: What technology areas does Scion Neurostim, Inc. focus on?

Scion Neurostim, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 29 patents, ranking #223 of 3,082 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 31 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Scion ranks #10,168 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 8 technology areas.

#10,168
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.3/100): 30.1
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10168 · US Corporation #10,168 · 31 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 31 grants
UPPER-Q #10,168/49,997
PHOTO-FINISH Rethink Robotics
CPC-NARROW A61F · 8 areas
INNOV-PAR 42.3/100
CLAIMS-DENSE 30.1 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rethink Robotics GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Scion’s 42.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.0 pts (28%) Velocity 5.3 pts (13%) Breadth 10.0 pts (24%) Claim depth 15.0 pts (35%)

Qualcomm Incorporated · highest

85
Conviva · near

42
Kangwon National… · near

42
Scion Neurostim · this assignee

42
Tate & Lyle… · near

42
Tealium · near

42
3D Lighting… · lowest

7

What this shows Scion's Innovation Score is 42.3/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Scion?

Each dot is one of Scion’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Scion’s own 30.1 claims/patent is ABOVE the 11.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Scion vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Scion's grants concentrate

Scion Neurostim, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 93.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2021 (5 grants) versus a trough of 2 in 2015. By volume, Scion sits between Rethink Robotics GmbH and Shenzhen Intellifusion Technologies Co., Ltd..

Scion's three-year grant acceleration

Scion Neurostim, Inc. shows 8 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Rethink Robotics

31
Rudolph

31
Samyang Biopharma…

31
SAN Fang Chemical…

31
Sennco Solutions

31
Ses-imagotag

31
Shenzhen Capchem…

31
Shenzhen Intellif…

31
Scion Neurostim ◀

31

What this shows Scion holds 31 patents at rank #10,165, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Scion

By rank, the assignees closest to #10,165 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Scion's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Scion, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Scion ranks #223 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Tate & Lyle Ingredients Americas LLC 42 Tealium Inc. 42 Kangwon National University University-Industry Cooperation Foundation 42 Conviva Inc. 42

Scion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Scion Neurostim, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	6.5%
2016	3	9.7%
2017	4	12.9%
2018	3	9.7%
2019	3	9.7%
2020	2	6.5%
2021	5	16.1%
2022	2	6.5%
2023	3	9.7%
2024	3	9.7%
2025partial year	1	3.2%

Which technologies does Scion Neurostim, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 29

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 20

A61B - DIAGNOSIS; SURGERY; Identification 14

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 10

H04R - Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

F25B - Refrigeration Machines, Plants OR SYSTEMS; Combined Heating AND Refrigeration SYSTEMS; Heat Pump Systems 1

H10N - Electric Solid-state Devices NOT Otherwise Provided FOR 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Scion Neurostim, Inc.'s patent record in context - here's where to go next.

Scion Neurostim, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 93.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #10,168 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Scion Neurostim, Inc. against Rethink Robotics GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.